|
[Related PubMed/MEDLINE]
Total Number of Papers: 152
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: L-ASP |
| Long Form |
: L-asparaginase |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. |
ALL, ASNS, ATF4, ChIP-seq |
| 2 |
2022 |
Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer. |
PCa |
| 3 |
2022 |
Comparative Effectiveness of Peg-Asparaginase and L-Asparaginase on Coagulation Markers Among Pediatric Patients with Acute Lymphoblastic Leukemia. |
ALL, ASP, ATIII, PEG-ASP, Pr-S, PrC, PT, PTT |
| 4 |
2022 |
L-Asparaginase-Induced Continuous Hyperglycemia With Type 1 Diabetes-Related Antibodies and HLA Genotypes: A Case Study. |
GAD, GRAALL, IA2 |
| 5 |
2022 |
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy. |
ALL, CNS, ICANS, MTX, VCR |
| 6 |
2022 |
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells. |
ASNS, PDSX |
| 7 |
2021 |
Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity. |
AAP, ALL |
| 8 |
2021 |
The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study. |
ENKTL, GELOXD, OS, PFS, PINK |
| 9 |
2020 |
Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia. |
ASP, IM |
| 10 |
2020 |
Antiproliferative effects of L-asparaginase in acute myeloid leukemia. |
AML, MIT |
| 11 |
2020 |
Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs. |
CR, MPFS, ORR, RAB |
| 12 |
2020 |
Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients. |
AEs, ALL, PEG-asp |
| 13 |
2020 |
National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia? |
ALL, PEG-Asp |
| 14 |
2020 |
Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches? |
ALL, LMWH, VTE |
| 15 |
2020 |
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. |
ALL, AT, VTE |
| 16 |
2020 |
[State-of-the-art therapy for adult Philadelphia chromosome-negative acute lymphoblastic leukemia]. |
ALL, allo-HSCT, MRD |
| 17 |
2019 |
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia. |
B-ALL, EFS, JACLS, OS |
| 18 |
2019 |
Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia. |
ALL, BFM, P-Peak, T-EP |
| 19 |
2019 |
Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment. |
--- |
| 20 |
2019 |
Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia. |
ALL, DNR, IGF-1R, VCR |
| 21 |
2019 |
EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. |
ASNS, EVI1, OXPHOS |
| 22 |
2019 |
Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP-ALL with PAX5 deletion. |
ASNS, BCP-ALL, CTSB, LGMN, PAX5, RFS |
| 23 |
2018 |
Hydrolytically Degradable PEGylated Polyelectrolyte Nanocomplexes for Protein Delivery. |
ELISA, GPC, PEG |
| 24 |
2018 |
Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase. |
ALL, AMLs, ASNS, t-MN |
| 25 |
2018 |
PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity. |
NK, OS, PEG-ASP |
| 26 |
2018 |
Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia. |
--- |
| 27 |
2018 |
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. |
DOX, OS, PFS |
| 28 |
2018 |
Selection and Evaluation of Appropriate Reference Genes for RT-qPCR Normalization of Volvariella volvacea Gene Expression under Different Conditions. |
ACTB, CyP, MSF1, SPRYp, TUBalpha, V. volvacea |
| 29 |
2018 |
[Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL]. |
ALL, allo-HSCT, CR, DFS, OS, Ph |
| 30 |
2018 |
[Recurrent thrombosed external hemorrhoids due to L-asparaginase administration in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient]. |
TEH |
| 31 |
2017 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type. |
IMEP, NK, PEG-ASP |
| 32 |
2017 |
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen. |
ALL, PEG |
| 33 |
2017 |
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma. |
ALL, LBL, PEG-ASP, PEG-ASP-BFM-90 |
| 34 |
2017 |
Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea. |
ALL, VTE |
| 35 |
2016 |
Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia. |
ALL, Gln, NK, PA, RBP |
| 36 |
2016 |
Endoscopic ultrasound-guided cystogastrostomy for successful drainage of pancreatic pseudocyst: a pediatric case report. |
ALL, EUS |
| 37 |
2016 |
Iatrogenic Coagulopathy and the Development of Posterior Reversible Encephalopathy Syndrome after L-asparaginase Chemotherapy. |
ATIII, PRES |
| 38 |
2016 |
L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha. |
ALL |
| 39 |
2016 |
TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia. |
DEX, DNR, MRD, T-ALL, VCR |
| 40 |
2016 |
[Comparison of the Effectiveness and Safety of Combined Chemotherapy with PEG-Asp for Treatment of ALL and T-NHL Patients]. |
ALL, PEG-Asp, T-NHL |
| 41 |
2016 |
[Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma]. |
ENKTCL, T-NHL |
| 42 |
2015 |
Catalytic Role of the Substrate Defines Specificity of Therapeutic l-Asparaginase. |
Asn |
| 43 |
2015 |
Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphoma. |
CR, IPI, L-ASP group, OR, OS, PFS, PR, PTCL |
| 44 |
2015 |
Effects of Prednisolone, L-Asparaginase, Gemfibrozil, and Combinations of These Elements on Mice Lipid Profile, Liver, and Pancreas. |
COL, CSs, HDL, LDL |
| 45 |
2015 |
L-Asparaginase monotherapy for EBV-positive T/NK lymphoproliferative diseases: A pilot Study. |
EBV |
| 46 |
2015 |
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. |
ALL, DEX, MTX |
| 47 |
2015 |
Reconstitution of L-Asparaginase in Siliconized Syringes with Shaking and Headspace Air Induces Protein Aggregation. |
--- |
| 48 |
2015 |
[A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy]. |
CR, OR, OS, PFS, PR |
| 49 |
2015 |
[Non-upper aerodigestive tract NK/T- cell lymphoma: an analysis of clinical features and survival from a single center in China]. |
NUAT-NKTCL, OS |
| 50 |
2014 |
A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety. |
--- |
| 51 |
2014 |
Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma. |
ASNS, bDNA-LCT, NK |
| 52 |
2014 |
Early diagnosis of asparaginase-associated pancreatitis based on elevated serum elastase-1 levels: Case reports. |
AAP, ALL |
| 53 |
2014 |
Efficacy and tolerance of pegaspargase-based chemotherapy in patients with nasal-type extranodal NK/T-cell lymphoma: a pilot study. |
APTT, CR, NK, ORR, PEG-Asp |
| 54 |
2014 |
Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma. |
DXM, GEM, NK, OS, PFS |
| 55 |
2014 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL). |
CI, HR, IMEP, IMEP, NTCL, NTCL, OS, PFS |
| 56 |
2014 |
L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report. |
ALL |
| 57 |
2014 |
L-asparaginase-induced severe acute pancreatitis in an adult with extranodal natural killer/T-cell lymphoma, nasal type: A case report and review of the literature. |
ENKTL, HBV |
| 58 |
2014 |
Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia. |
AST, BUN, CRP, L-AP, LDH, MCSI, TPN |
| 59 |
2014 |
Targeted metabolomic analysis of amino acid response to L-asparaginase in adherent cells. |
--- |
| 60 |
2014 |
The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells. |
ASNS |
| 61 |
2014 |
[Advances of treatment for nature killer/T-cell lymphoma]. |
EBV, NKTCL |
| 62 |
2014 |
[Advances on the role of pegaspargase in the treatment of childhood leukemia]. |
PEG-ASP |
| 63 |
2014 |
[Efficacy of chemotherapy combined with bortezomib for two cases of relapsed/refractory acute lymphoblastic leukemia]. |
ALL, BZM |
| 64 |
2013 |
Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia. |
ALL, DNR, MNCs, PCA, PS |
| 65 |
2013 |
Delayed-type hypersensitivity in response to L-asparaginase in a case of acute lymphoblastic leukemia. |
--- |
| 66 |
2013 |
Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines. |
ASNS |
| 67 |
2013 |
Monitoring of anti-L-asparaginase antibody and L-asparaginase activity levels in a pediatric patient with acute lymphoblastic leukemia and hypersensitivity to native Escherichia coli L-asparaginase during desensitization courses. |
--- |
| 68 |
2013 |
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy. |
ALL |
| 69 |
2013 |
[Analysis of L-asparaginase induced elevation of blood ammonia and hepatic encephalopathy]. |
--- |
| 70 |
2013 |
[Update on L-asparaginase treatment in paediatrics]. |
--- |
| 71 |
2012 |
Acute hyperammonemia after L-asparaginase administration in a dog. |
--- |
| 72 |
2012 |
Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Munster-based induction therapy for childhood acute lymphoblastic leukemia. |
ALL, BFM, BM, PB |
| 73 |
2012 |
Conservative management of L-asparaginase-induced hypertriglyceridemia in an adult patient: a case report and review of the literature. |
--- |
| 74 |
2012 |
Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report. |
--- |
| 75 |
2012 |
L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. |
HMVEC |
| 76 |
2012 |
Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase. |
ALL, ASNS |
| 77 |
2012 |
The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia. |
ALL, AT |
| 78 |
2012 |
[Allergic complications of L-asparaginase therapy in children with acute lymphoblastic leukaemia]. |
ALL |
| 79 |
2012 |
[Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia]. |
ALL |
| 80 |
2011 |
Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. |
ALL |
| 81 |
2011 |
Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction. |
ALL |
| 82 |
2009 |
Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. |
ALL, AP |
| 83 |
2009 |
Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase. |
ALL, AP, CT |
| 84 |
2009 |
Asparagine synthetase: a new potential biomarker in ovarian cancer. |
ASNS |
| 85 |
2009 |
Dexamethasone induces a heat-stress response that ameliorates the conformational consequences on antithrombin of L-asparaginase treatment. |
ER, HSR, UPR |
| 86 |
2009 |
Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma. |
AML, AS, CR, NHL |
| 87 |
2009 |
Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia. |
ADR, ALL, FRALLE, GC, PCA, PPL, TFa, VCR |
| 88 |
2009 |
[Side effects of L-asparaginase during therapies for remission induction and maintenance in children with acute lymphocytic leukemia]. |
ALL |
| 89 |
2008 |
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. |
ASNS |
| 90 |
2008 |
Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines. |
DEX, GSIs, T-ALL |
| 91 |
2008 |
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia. |
ALL, CR, DFS, OS, Ph, PSL, VCR |
| 92 |
2008 |
Purification of Escherichia coli L-asparaginase mutants by a native polyacrylamide gel electrophoresis. |
--- |
| 93 |
2007 |
Enhanced secretion of adhesive recognition sequence containing hirudin III mutein in E. coli. |
--- |
| 94 |
2007 |
Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples. |
ABCB1, ASNS, ASS1, DNR, PRED, T-ALL, VCR |
| 95 |
2007 |
[Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]. |
ALL, SSST |
| 96 |
2006 |
Probing the antigenicity of E. coli L-asparaginase by mutational analysis. |
--- |
| 97 |
2006 |
Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia. |
ALL, AS, PEG-Asp |
| 98 |
2006 |
[Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia]. |
6-MP, ALL, CPM, DNR, DOX, DPOAEs, MTX, OAEs, VCR |
| 99 |
2006 |
[Preliminary study on the safety and pharmacodynamic action of low dose L-asparaginase]. |
ALL, RP-HPLC |
| 100 |
2006 |
[Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase]. |
CT, FLAIR, MRI, RPLS |
|
A Search Service for Abbreviation / Long Form
